Aceso Advances Complementary Peptide Approaches to Enhance CFTR Function
Vienna, Austria – September 6–11, 2026 — Aceso Therapeutics is presenting new research at the 38th European Peptide Symposium, highlighting promising advances in peptide-based approaches to address key challenges in cystic fibrosis (CF). Prisca Boisguerin, PhD, CTO and co-founder of Aceso Therapeutics, is presenting research focused on the development of innovative peptides designed to improve […]
A proud moment for the entire Aceso Therapeutics team
🏆 A proud moment for the entire Aceso Therapeutics team: ACT-101 has been selected as a winner of the 2026 i-Lab Innovation Competition (28th edition), supported by Bpifrance under the France 2030 initiative! 🎉
Innovation Award 2025
🎉 Congratulations to Magali Taulan-Cadars and Prisca Boisguerin for winning the 2025 Innovation « Coup de cœur » Award with their StabCFTR project, aiming to improve care for cystic fibrosis patients. 🏆 The award was presented on July 8, 2025, at the 6th Innovation Afterwork hosted by the University of Montpellier at the beautiful Jardin des Plantes. […]